Merendino Lauren (CIK 1855298) reported 18 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-23). Recent activity: Sell DAWN (60,157 shares), Buy DAWN (3,162 shares), Buy DAWN (3,688 shares), Buy DAWN (3,687 shares), Buy DAWN (4,625 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-23 | Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | Sell | 60,157 | $0 |
| 2026-02-18 | Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | Buy | 3,162 | $0 |
| 2026-02-18 | Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | Buy | 3,688 | $0 |
| 2026-02-18 | Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | Buy | 3,687 | $0 |
| 2026-02-18 | Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | Buy | 4,625 | $0 |
| 2026-02-18 | Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | Sell | 5,814 | $67,442 |
| 2025-11-18 | Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | Buy | 3,162 | $0 |
| 2025-11-18 | Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | Buy | 3,687 | $0 |
| 2025-11-18 | Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | Buy | 3,687 | $0 |
| 2025-11-18 | Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | Sell | 3,726 | $33,199 |
| 2025-08-19 | Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | Buy | 3,162 | $0 |
| 2025-08-19 | Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | Buy | 3,687 | $0 |
| 2025-08-19 | Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | Buy | 3,687 | $0 |
| 2025-08-19 | Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | Sell | 3,766 | $25,496 |
| 2025-05-19 | Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | Buy | 3,162 | $0 |
| 2025-05-19 | Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | Buy | 3,687 | $0 |
| 2025-05-19 | Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | Buy | 3,687 | $0 |
| 2025-05-19 | Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | Sell | 3,927 | $24,583 |
Source: SEC Form 4 filings · as of 2026-04-23